Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 17.72% is 841% above its 5-year average of -2.39%, near the high end of its 5-year range (-20.13%–17.72%).
As of the fiscal period ended Tuesday, June 30, 2026. 67.13% above its 12-month average of 10.60%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 17.72%.
RETURN ON EQUITY (ROE)
17.72%
RETURN ON EQUITY (ROE) AVG TTM
10.60%
RETURN ON EQUITY (ROE) AVG 3Y
4.71%
RETURN ON EQUITY (ROE) AVG 5Y
-2.39%
RETURN ON EQUITY (ROE) AVG 10Y
-0.93%
RETURN ON EQUITY (ROE) AVG 15Y
1.04%
RETURN ON EQUITY (ROE) AVG 20Y
-20.70%
CURRENT VS TTM AVG
+67.13%
CURRENT VS 3Y AVG
+276.21%
CURRENT VS 5Y AVG
+840.73%
CURRENT VS 10Y AVG
+2011.39%
CURRENT VS 15Y AVG
+1600.59%
CURRENT VS 20Y AVG
+185.62%
SECTOR MEDIAN · HEALTHCARE
-40.21%
median of 627 covered companies
CURRENT VS SECTOR MEDIAN
+144.07%
vs the sector median at left
ANI Pharmaceuticals, Inc.
Market Cap
$1.63B
Return on Equity (ROE)
17.72%
TTM Avg
10.60%
3Y Avg
4.71%
5Y Avg
-2.39%
Market Cap
$1.63B
Return on Equity (ROE)
-57.97%
TTM Avg
-51.00%
3Y Avg
-97.84%
5Y Avg
-100.56%
Market Cap
$1.61B
Return on Equity (ROE)
-67.40%
TTM Avg
-53.05%
3Y Avg
2.62%
5Y Avg
2.10%
Market Cap
$1.65B
Return on Equity (ROE)
N/A
TTM Avg
-1058.20%
3Y Avg
-465.87%
5Y Avg
-348.95%
Market Cap
$1.60B
Return on Equity (ROE)
3.03%
TTM Avg
0.59%
3Y Avg
-0.01%
5Y Avg
1.68%
Market Cap
$1.70B
Return on Equity (ROE)
-45.58%
TTM Avg
-35.59%
3Y Avg
-51.70%
5Y Avg
-41.50%
Market Cap
$1.54B
Return on Equity (ROE)
28.97%
TTM Avg
13.25%
3Y Avg
22.73%
5Y Avg
32.77%
Market Cap
$1.54B
Return on Equity (ROE)
45.63%
TTM Avg
28.57%
3Y Avg
-115.12%
5Y Avg
-36.89%
Market Cap
$1.54B
Return on Equity (ROE)
-77.83%
TTM Avg
1723.94%
3Y Avg
818.18%
5Y Avg
546.13%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| ANI Pharmaceuticals, Inc. (ANIP) | $1.63B | 17.72% | 10.60% | 4.71% | -2.39% |
| Ocular Therapeutix, Inc. (OCUL)vs › | $1.63B | -57.97% | -51.00% | -97.84% | -100.56% |
| Kestra Medical Technologies, Ltd. (KMTS)vs › | $1.61B | -67.40% | -53.05% | 2.62% | 2.10% |
| Alphatec Holdings, Inc. (ATEC)vs › | $1.65B | N/A | -1058.20% | -465.87% | -348.95% |
| Omnicell, Inc. (OMCL)vs › | $1.60B | 3.03% | 0.59% | -0.01% | 1.68% |
| Personalis, Inc. (PSNL)vs › | $1.70B | -45.58% | -35.59% | -51.70% | -41.50% |
| Innoviva, Inc. (INVA)vs › | $1.54B | 28.97% | 13.25% | 22.73% | 32.77% |
| Nutex Health, Inc. (NUTX)vs › | $1.54B | 45.63% | 28.57% | -115.12% | -36.89% |
| uniQure N.V. (QURE)vs › | $1.54B | -77.83% | 1723.94% | 818.18% | 546.13% |
| DENTSPLY SIRONA Inc. (XRAY)vs › | $1.73B | -40.41% | -45.75% | -30.11% | -18.95% |
ROE
17.7%
ROA
7.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 17.72% |
| 2026-03-31 | 15.95% |
| 2025-12-31 | 14.03% |
| 2025-09-30 | 7.53% |
| 2025-06-30 | -2.21% |
| 2025-03-31 | -4.75% |
| 2024-12-31 | -4.32% |
| 2024-09-30 | -1.65% |
| 2024-06-30 | 5.62% |
| 2024-03-31 | 7.46% |
| 2023-12-31 | 4.10% |
| 2023-09-30 | 2.94% |
| 2023-06-30 | -1.19% |
| 2023-03-31 | -7.76% |
| 2022-12-31 | -14.15% |
| 2022-09-30 | -20.13% |
| 2022-06-30 | -18.89% |
| 2022-03-31 | -18.15% |
| 2021-12-31 | -11.88% |
| 2021-09-30 | -11.55% |
| 2021-06-30 | -8.97% |
| 2021-03-31 | -7.58% |
| 2020-12-31 | -11.52% |
| 2020-09-30 | -12.17% |
| 2020-06-30 | -10.64% |
| 2020-03-31 | -0.76% |
| 2019-12-31 | 2.78% |
| 2019-09-30 | 7.57% |
| 2019-06-30 | 8.32% |
| 2019-03-31 | 6.79% |
| 2018-12-31 | 7.78% |
| 2018-09-30 | 0.18% |
| 2018-06-30 | 0.02% |
| 2018-03-31 | -0.03% |
| 2017-12-31 | -0.65% |
| 2017-09-30 | 4.05% |
| 2017-06-30 | 2.97% |
| 2017-03-31 | 2.15% |
| 2016-12-31 | 2.30% |
| 2016-09-30 | 4.65% |
| 2016-06-30 | 6.02% |
| 2016-03-31 | 7.67% |
| 2015-12-31 | 9.55% |
| 2015-09-30 | 21.40% |
| 2015-06-30 | 23.74% |
| 2015-03-31 | 20.44% |
| 2014-12-31 | 20.45% |
| 2014-09-30 | 11.13% |
| 2014-06-30 | 6.10% |
| 2014-03-31 | 3.65% |
| 2013-12-31 | -5.54% |
| 2013-09-30 | -26.41% |
| 2013-06-30 | -47.85% |
| 2013-03-31 | -75.85% |
| 2012-12-31 | -98.38% |
| 2012-09-30 | -94.08% |
| 2012-06-30 | -119.63% |
| 2012-03-31 | -117.44% |
| 2011-12-31 | -136.48% |
| 2011-09-30 | -131.90% |
| 2011-06-30 | -495.10% |
| 2011-03-31 | -202.43% |
| 2010-12-31 | -241.27% |
| 2010-09-30 | -427.41% |
| 2010-06-30 | -226.07% |
| 2010-03-31 | -234.80% |
| 2009-12-31 | -300.23% |
| 2009-09-30 | -144.94% |
| 2009-06-30 | -282.50% |
| 2009-03-31 | -176.53% |
| 2008-12-31 | -126.03% |
| 2008-09-30 | -117.59% |
| 2008-06-30 | -62.98% |
| 2008-03-31 | -36.42% |
| 2007-12-31 | -25.51% |
| 2007-09-30 | 9.88% |
| 2007-06-30 | 12.37% |
| 2007-03-31 | 25.29% |
| 2006-12-31 | 15.45% |
| 2006-09-30 | -95.74% |
| 2006-06-30 | -378.29% |
| 2006-03-31 | -215.41% |
| 2005-12-31 | -141.53% |
| 2005-09-30 | -123.49% |
| 2005-06-30 | -112.86% |
| 2005-03-31 | -92.13% |
| 2004-12-31 | -75.48% |
| 2004-09-30 | -48.39% |
| 2004-06-30 | -36.61% |
| 2004-03-31 | -95.15% |
| 2003-12-31 | -68.62% |
| 2003-09-30 | -46.20% |
| 2003-06-30 | -201.73% |
